<- Go Home
iCAD, Inc.
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy.
Market Cap
$41.6M
Volume
165.0K
Cash and Equivalents
$18.8M
EBITDA
-$5.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$16.6M
Profit Margin
87.51%
52 Week High
$2.65
52 Week Low
$1.18
Dividend
N/A
Price / Book Value
1.42
Price / Earnings
-7.85
Price / Tangible Book Value
1.99
Enterprise Value
$23.3M
Enterprise Value / EBITDA
-4.55
Operating Income
-$5.9M
Return on Equity
-17.56%
Return on Assets
-8.95
Cash and Short Term Investments
$18.8M
Debt
$415.0K
Equity
$29.4M
Revenue
$18.9M
Unlevered FCF
-$2.1M
Sector
Health Care Technology
Category
N/A